Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Mesenchymal Stem Cells, Advances and Applications
2.
Pharmacodynamic Assays Market Report
3.
Stem Cell Research Products
4.
Poly(ADP-ribose) polymerase (PARP) Research Products
5.
Advances in Biopharmaceutical Technology in India
6.
Directory of Top 60 Biopharmaceutical Manufacturers in China
7.
Directory of Top 60 Biopharmaceutical Manufacturers in India
8.
Outsourcing for contract manufacturing services 2008-2023
9.
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
10.
Pfizer - Market Outlook for a Global Leader, 2008-2013
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
3.
The Global Rheumatoid Arthritis Market Forecasts to 2012
4.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
5.
Biostatistics course
6.
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
Outsourcing in Drug Discovery, 3rd Edition
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations.
Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market.
Segments covered in this report include:
Chemistry Services
Building Blocks
Compound Synthesis
Libraries
Process Research
Other Services
Biology Services
Protein Expression
Structural Analysis
Target Validation
Pathways Analysis
Other Services
Screening Services
Assay Development
Primary Screening
Secondary Screening
Lead Optimization
Early ADMET
Analogues Creation
Computational Support
Other services
In addition to market data and forecasts, the report covers issues such as:
What factors should a client consider when deciding whether to do a project in-house or outsource it?
Is it in the client's best interest to seek a domestic outsourcing partner, or go with an overseas supplier?
How does the client select the CRO that is best for him?
What are the best practices when working with a CRO?
How do you measure his effectiveness?
How do you avoid problems with your CRO?
How do you maximize benefits?
This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why.
May 1, 2008 250 Pages
Table of Contents
Price
$3,900.00 Hard copy postal mail deliver
$7,000.00 Global Site Licence
$4,300.00 Online download plus 1 hard copy
$3,500.00 Online Download
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.